Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51	78	160	45	265	306
Market Cap Growth	29.49%	-51.05%	255.34%	-83.01%	-13.37%	12.54%
Enterprise Value	35	83	143	31	246	237
Last Close Price	0.13	0.20	0.46	0.25	1.49	1.94
PS Ratio	11.05	19.61	40.05	1.66	10.55	32.49
PB Ratio	0.83	1.85	2.68	0.91	3.62	4.88
P/TBV Ratio	0.84	1.86	4.73	2.06	5.72	8.81
EV/Sales Ratio	7.50	20.71	35.72	1.14	9.76	25.09
Debt / Equity Ratio	0.07	0.10	0.14	0.24	0.14	0.20
Net Debt / Equity Ratio	-0.27	-0.10	-0.17	-0.03	-0.45	-0.52
Net Debt / EBITDA Ratio	0.70	0.16	0.41	0.05	1.17	1.46
Net Debt / FCF Ratio	-2.33	0.19	0.45	0.05	1.03	1.95
Asset Turnover	0.07	0.06	0.05	0.31	0.26	0.10
Inventory Turnover	0.43	0.39	0.20	1.57	1.77	1.43
Quick Ratio	4.47	0.61	2.94	1.34	2.65	2.91
Current Ratio	5.28	2.75	3.83	1.94	3.10	3.30
Return on Equity (ROE)	4.80%	-54.40%	-43.45%	-43.88%	-36.14%	-27.93%
Return on Assets (ROA)	-20.82%	-24.45%	-21.74%	-21.83%	-19.36%	-16.24%
Return on Capital Employed (ROCE)	-36.60%	-62.20%	-39.60%	-53.10%	-37.00%	-31.50%
Earnings Yield	0.98%	-36.60%	-13.55%	-59.67%	-9.27%	-6.63%
FCF Yield	13.78%	-28.69%	-14.23%	-62.33%	-12.05%	-5.47%
Buyback Yield / Dilution	-17.86%	-18.20%	-72.61%	-10.28%	-5.54%	-28.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.